SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genomic Valley Biotech informs about press release

10 Dec 2025 Evaluate

Genomic Valley Biotech has informed that it enclosed copies of the newspaper advertisement published in the ‘Financial Express’ (English) and (Hindi) newspaper ‘Jansatta’ dated 10th December, 2025 with respect to Notice of 31st Annual General Meeting to be held on Wednesday 31st December, 2025 at 09:00 AM through Physical Means.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

27.45 1.30 (4.97%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1460.05
Mangalam Global Ent 11.95
Kaveri Seed 925.15
Regaal Resources 78.78
Simran Farms 156.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×